Clinical Trials Directory

Trials / Completed

CompletedNCT03434340

Aromatherapy for Prevention of Intrathecal Morphine Induced Nausea and Vomiting

Aromatherapy as Prophylaxis for Prevention of Intrathecal Morphine Induced Nausea and Vomiting in Lower Segment Cesarean Section

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
155 (actual)
Sponsor
Universiti Kebangsaan Malaysia Medical Centre · Academic / Other
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

This study evaluates the effect of combining non pharmacological anti emetic prophylaxis, namely peppermint essential oil to granisetron and dexamethasone in patient who receive intrathecal morphine for lower segment cesarean section. Half of the patient will receive nasal strip containing peppermint essential oil in addition to granisetron and dexamethasone while the other half will only receive granisetron and dexamethasone.

Detailed description

It is not uncommon to use different group of anti emetic in order to achieve high successful rate in the prevention of opioid induced nausea and vomiting. This study evaluates the effect of combining non pharmacological and pharmacological method to prevent such condition. Aromatherapy has been used since many years to treat nausea and vomiting. One of the proposed mechanism is by the activation of olfactory receptor when the molecules of essential oil absorb in the mucus lining olfactory epithelium. The signal is then carried by olfactory sensory neuron to the olfactory bulb which filters and send signal to olfactory cortex as well as limbic system to give the feeling of well being. Granisetron is a serotonin 3 receptor antagonist prevent or treat nausea and vomiting by competitively blocks the action of serotonin at 5-hydroxytryptamine 3 (5HT3) receptors while the mechanism of action of dexamethasone; which is a glucocorticoids is not fully understood.

Conditions

Interventions

TypeNameDescription
BIOLOGICALPeppermint essential oil2 drops applied on a nasal strip
DRUGGranisetron1mg intravenous injection
DRUGDexamethasone4mg intravenous injection

Timeline

Start date
2018-06-26
Primary completion
2019-03-22
Completion
2019-04-02
First posted
2018-02-15
Last updated
2019-04-18

Locations

1 site across 1 country: Malaysia

Source: ClinicalTrials.gov record NCT03434340. Inclusion in this directory is not an endorsement.